top of page
REVIEWS, ABSTRACTS, AND ORIGINAL ARTICLES
Authored Publications
NUMBER OF PUBLICATIONS:
89
2025 Feb 19
Cardiovascular Outcomes with Icosapent Ethyl by Baseline Low‐Density Lipoprotein Cholesterol: A Secondary Analysis of the REDUCE‐IT Randomized Trial
Journal of the American Heart Association
14(5):e038656
Article
2025 Feb 13
Effect of sotagliflozin on major adverse cardiovascular events: a prespecified secondary analysis of the SCORED a randomised trial
The Lancet Diabetes & Endocrinology
S2213-8587(24)00362-0
Article
2024 Oct 23
“A Time to Tear Down and a Time to Mend” – The Role of Eicosanoids in Atherosclerosis
Arteriosclerosis, Thrombosis, and Vascular Biology
44(11):2258-2263
Article
2024 Nov 11
REDUCE-IT, biomarkers, and confirmation bias: are we missing the forest for the trees?
European Journal of Preventive Cardiology
31(15):e113-e114
Article
European Journal of Preventive Cardiology
31(8):1005-1014
Article
2024 Jul 16
Eicosapentaenoic acid improves endothelial nitric oxide bioavailability via changes in protein expression during inflammation
Journal of the American Heart Association
13(14):e034076
Article
Cardiovascular Research
119(18):2884-2901
Article
Journal of the American College of Cardiology
83 (16):1529-1539
Article
2023 Nov 23
Omega-3 Fatty Acids Influence Membrane Cholesterol Distribution and Crystal Formation in Models of Atherosclerosis
Cholesterol Crystals in Atherosclerosis and Other Related Diseases
pp. 297-318
Article
bottom of page